These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
986 related items for PubMed ID: 11559025
1. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Chen H, Liu J, Zhao CQ, Diwan BA, Merrick BA, Waalkes MP. Toxicol Appl Pharmacol; 2001 Sep 15; 175(3):260-8. PubMed ID: 11559025 [Abstract] [Full Text] [Related]
2. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP. Toxicol Appl Pharmacol; 2005 Aug 15; 206(3):288-98. PubMed ID: 16039940 [Abstract] [Full Text] [Related]
3. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro. Shimizu M, Hochadel JF, Fulmer BA, Waalkes MP. Toxicol Sci; 1998 Oct 15; 45(2):204-11. PubMed ID: 9848127 [Abstract] [Full Text] [Related]
4. Sodium arsenite alters cell cycle and MTHFR, MT1/2, and c-Myc protein levels in MCF-7 cells. Ruiz-Ramos R, López-Carrillo L, Albores A, Hernández-Ramírez RU, Cebrian ME. Toxicol Appl Pharmacol; 2009 Dec 15; 241(3):269-74. PubMed ID: 19766132 [Abstract] [Full Text] [Related]
5. Up-regulation of cyclin D1 by JNK1/c-Jun is involved in tumorigenesis of human embryo lung fibroblast cells induced by a low concentration of arsenite. Li Y, Shen L, Xu H, Pang Y, Xu Y, Ling M, Zhou J, Wang X, Liu Q. Toxicol Lett; 2011 Oct 10; 206(2):113-20. PubMed ID: 21726611 [Abstract] [Full Text] [Related]
6. p52-Bcl3 complex promotes cyclin D1 expression in BEAS-2B cells in response to low concentration arsenite. Wang F, Shi Y, Yadav S, Wang H. Toxicology; 2010 Jun 29; 273(1-3):12-8. PubMed ID: 20420878 [Abstract] [Full Text] [Related]
7. Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic. Liu J, Xie Y, Ward JM, Diwan BA, Waalkes MP. Toxicol Sci; 2004 Feb 29; 77(2):249-57. PubMed ID: 14691202 [Abstract] [Full Text] [Related]
8. Further studies on aberrant gene expression associated with arsenic-induced malignant transformation in rat liver TRL1215 cells. Liu J, Benbrahim-Tallaa L, Qian X, Yu L, Xie Y, Boos J, Qu W, Waalkes MP. Toxicol Appl Pharmacol; 2006 Nov 01; 216(3):407-15. PubMed ID: 16876216 [Abstract] [Full Text] [Related]
9. Dose response evaluation of gene expression profiles in the skin of K6/ODC mice exposed to sodium arsenite. Ahlborn GJ, Nelson GM, Ward WO, Knapp G, Allen JW, Ouyang M, Roop BC, Chen Y, O'Brien T, Kitchin KT, Delker DA. Toxicol Appl Pharmacol; 2008 Mar 15; 227(3):400-16. PubMed ID: 18191166 [Abstract] [Full Text] [Related]
10. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice. Waalkes MP, Liu J, Ward JM, Diwan BA. Toxicol Appl Pharmacol; 2004 Aug 01; 198(3):377-84. PubMed ID: 15276417 [Abstract] [Full Text] [Related]
11. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis. Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB. Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672 [Abstract] [Full Text] [Related]
13. Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation. Waalkes MP, Liu J, Ward JM, Diwan BA. Toxicology; 2004 May 20; 198(1-3):31-8. PubMed ID: 15138027 [Abstract] [Full Text] [Related]
14. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation. Bazarov AV, Adachi S, Li SF, Mateyak MK, Wei S, Sedivy JM. Cancer Res; 2001 Feb 01; 61(3):1178-86. PubMed ID: 11221849 [Abstract] [Full Text] [Related]
15. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2. Choe C, Chen N, Sawadogo M. Exp Cell Res; 2005 Jan 01; 302(1):1-10. PubMed ID: 15541720 [Abstract] [Full Text] [Related]
16. Arsenic induces overexpression of growth factors in human keratinocytes. Germolec DR, Yoshida T, Gaido K, Wilmer JL, Simeonova PP, Kayama F, Burleson F, Dong W, Lange RW, Luster MI. Toxicol Appl Pharmacol; 1996 Nov 01; 141(1):308-18. PubMed ID: 8917704 [Abstract] [Full Text] [Related]
17. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice. Wang Y, Thakur A, Sun Y, Wu J, Biliran H, Bollig A, Liao DJ. Cancer Res; 2007 Apr 15; 67(8):3698-707. PubMed ID: 17440082 [Abstract] [Full Text] [Related]
18. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS. Oncogene; 2000 Oct 19; 19(44):5054-62. PubMed ID: 11042693 [Abstract] [Full Text] [Related]
19. Sodium arsenite-induced DAPK promoter hypermethylation and autophagy via ERK1/2 phosphorylation in human uroepithelial cells. Huang YC, Hung WC, Chen WT, Yu HS, Chai CY. Chem Biol Interact; 2009 Oct 07; 181(2):254-62. PubMed ID: 19577553 [Abstract] [Full Text] [Related]
20. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Simeonova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V, Luster MI. Cancer Res; 2000 Jul 01; 60(13):3445-53. PubMed ID: 10910055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]